Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020
Abstract Aim Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. Methods Patients w...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.863 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849732045690896384 |
|---|---|
| author | Meharan Pournazari Tara Hashemi Mahsa Zarpoosh Parsa Amirian |
| author_facet | Meharan Pournazari Tara Hashemi Mahsa Zarpoosh Parsa Amirian |
| author_sort | Meharan Pournazari |
| collection | DOAJ |
| description | Abstract Aim Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. Methods Patients who were referred to Kermanshah's rheumatologic clinics by an ophthalmologist from 2018 to 2020 for a rheumatologist visit were included. A checklist for extracting data from medical files; containing symptoms, organ involvement, ocular diseases diagnosed by an ophthalmologist, rheumatologic diseases diagnosed by a rheumatologist, lab tests, and disease progression was created. After we evaluated the medical data, we found that 54 patients out of 106 were diagnosed to have immune‐mediated rheumatological diseases. Patients were divided into two groups; the first group included patients with diagnosed immune‐mediated rheumatologic disease and ophthalmic complications; patients with no known immune‐mediated rheumatological disease were considered the second group. The obtained information was analyzed using statistical tests. Results One hundred and six patients participated in this study, 67% of whom were females. The most common ocular symptom was blurred vision (49%). Involvement of both eyes (43.4%) was more common than single left or right eye involvement. The most common ophthalmic disease was anterior uveitis (35.8%). The most common rheumatologic disease was Behçet's disease (21.7%). Hypertension and hypothyroidism were the most common comorbidities; 36.7% of the patients had skin and mucous involvement, and 37.7% had joint involvement. In follow‐up of the ophthalmic symptoms, most patients were controlled partially. Ophthalmic diseases, laboratory tests, joint involvement, skin and mucous involvement, and lung involvement were associated with rheumatologic diseases. Conclusion Early diagnosis of ocular involvement in rheumatologic diseases is crucial to prevent adverse complications. The results can be beneficial for a better perception of ophthalmic symptoms and diseases among patients with autoimmune diseases. |
| format | Article |
| id | doaj-art-e5f96d2026dc481091518d1990683366 |
| institution | DOAJ |
| issn | 2050-4527 |
| language | English |
| publishDate | 2023-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | Immunity, Inflammation and Disease |
| spelling | doaj-art-e5f96d2026dc481091518d19906833662025-08-20T03:08:21ZengWileyImmunity, Inflammation and Disease2050-45272023-05-01115n/an/a10.1002/iid3.863Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020Meharan Pournazari0Tara Hashemi1Mahsa Zarpoosh2Parsa Amirian3Department of Rheumatology, Imam Reza Hospital Kermanshah University of Medical Sciences (KUMS) Kermanshah IranKermanshah University of Medical Science (KUMS) Kermanshah IranKermanshah University of Medical Science (KUMS) Kermanshah IranKermanshah University of Medical Science (KUMS) Kermanshah IranAbstract Aim Autoimmune diseases are presented with many signs and symptoms. Eyes are commonly involved in these diseases. This study aimed to estimate the prevalence of different ophthalmological complications in patients with and without immune‐mediated rheumatological diseases. Methods Patients who were referred to Kermanshah's rheumatologic clinics by an ophthalmologist from 2018 to 2020 for a rheumatologist visit were included. A checklist for extracting data from medical files; containing symptoms, organ involvement, ocular diseases diagnosed by an ophthalmologist, rheumatologic diseases diagnosed by a rheumatologist, lab tests, and disease progression was created. After we evaluated the medical data, we found that 54 patients out of 106 were diagnosed to have immune‐mediated rheumatological diseases. Patients were divided into two groups; the first group included patients with diagnosed immune‐mediated rheumatologic disease and ophthalmic complications; patients with no known immune‐mediated rheumatological disease were considered the second group. The obtained information was analyzed using statistical tests. Results One hundred and six patients participated in this study, 67% of whom were females. The most common ocular symptom was blurred vision (49%). Involvement of both eyes (43.4%) was more common than single left or right eye involvement. The most common ophthalmic disease was anterior uveitis (35.8%). The most common rheumatologic disease was Behçet's disease (21.7%). Hypertension and hypothyroidism were the most common comorbidities; 36.7% of the patients had skin and mucous involvement, and 37.7% had joint involvement. In follow‐up of the ophthalmic symptoms, most patients were controlled partially. Ophthalmic diseases, laboratory tests, joint involvement, skin and mucous involvement, and lung involvement were associated with rheumatologic diseases. Conclusion Early diagnosis of ocular involvement in rheumatologic diseases is crucial to prevent adverse complications. The results can be beneficial for a better perception of ophthalmic symptoms and diseases among patients with autoimmune diseases.https://doi.org/10.1002/iid3.863anterior uveitisBehçet's diseaseblurred visioneye diseasesocular manifestationrheumatology diseases |
| spellingShingle | Meharan Pournazari Tara Hashemi Mahsa Zarpoosh Parsa Amirian Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 Immunity, Inflammation and Disease anterior uveitis Behçet's disease blurred vision eye diseases ocular manifestation rheumatology diseases |
| title | Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 |
| title_full | Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 |
| title_fullStr | Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 |
| title_full_unstemmed | Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 |
| title_short | Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020 |
| title_sort | ocular manifestations in iranian patients referred to rheumatology clinics from 2018 to 2020 |
| topic | anterior uveitis Behçet's disease blurred vision eye diseases ocular manifestation rheumatology diseases |
| url | https://doi.org/10.1002/iid3.863 |
| work_keys_str_mv | AT meharanpournazari ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020 AT tarahashemi ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020 AT mahsazarpoosh ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020 AT parsaamirian ocularmanifestationsiniranianpatientsreferredtorheumatologyclinicsfrom2018to2020 |